Lead party: Hikma Ventures (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: O7 Therapy
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Seed · Deal amount: US$2.1m
Investors/buyers: Hikma Ventures, C-Ventures, Lotus Ventures
Legal advisers: not identified in the source record.
Source: announced 13 April 2022. Original announcement: wamda.com.


